LENZ Therapeutics, Inc.

LENZ · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$50-$70-$101-$71
Dep. & Amort.$0$0$8$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$1$0$0
Change in WC-$13$9-$7-$2
Other Non-Cash-$3-$1$12$20
Operating Cash Flow-$59-$60-$88-$53
Investing Activities
PP&E Inv.-$0-$0-$7-$6
Net Acquisitions$0$0$0$0
Inv. Purchases-$242-$52-$406$0
Inv. Sales/Matur.$88$23$170$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$154-$30-$242-$6
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$80$0$1$417
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$119$81$0$0
Financing Cash Flow$199$81$1$417
Forex Effect$0$0$0-$2
Net Chg. in Cash-$15-$9-$329$357
Supplemental Information
Beg. Cash$35$44$377$20
End Cash$20$35$48$377
Free Cash Flow-$60-$60-$95-$59
LENZ Therapeutics, Inc. (LENZ) Financial Statements & Key Stats | AlphaPilot